Dallah Healthcare

What Dallah Healthcare does

Dallah Healthcare Holding Company is a Riyadh-headquartered integrated healthcare provider founded in 1987 and listed on the Saudi Exchange (Tadawul) under ticker 4004 since 2012. The company operates 13 medical facilities across the Central, Western, Eastern, and Makkah regions of Saudi Arabia, comprising more than 2,560 beds and 820 outpatient clinics, staffed by over 1,000 specialist consultants. It serves approximately 3.8 million patient visits annually across five operating segments: Hospital Services, Clinic Services, Home Healthcare, Pharmaceutical Distribution (Dallah Pharma), and Facility Management.

The company's revenue model is built on fee-for-service healthcare delivery to individual patients and families, supplemented by B2B contracts with healthcare institutions and government entities for pharmaceutical distribution and outsourced facility management. Dallah's technical and operational backbone includes accredited clinical pathways (JCI, CAP, SRC, CBAHI, ISO, HIMSS Stage 6, ICHOM, GHA), an electronic health record platform spanning its hospital and clinic network, and emerging telemedicine and AI-assisted diagnostic capabilities. The group also holds a real estate vehicle, the Wahat Al-Nakheel Real Estate Fund, which provides a captive property and leasing infrastructure for healthcare assets.

Dallah monetizes its integrated platform through cross-segment referrals, captive demand for its pharma supply chain, and recurring facility management contracts. Its hospital segment anchors revenue, with clinic, home care, pharma, and facility management extending the patient relationship and creating internal volume capture. Recent strategic activity has emphasized inorganic expansion (Kingdom Hospital, Al Salam/Al Ahsa), greenfield capacity (Al Arid specialty hospital), and digital transformation aligned with Saudi Vision 2030 priorities.

Name

Dallah Healthcare

Legal name

Dallah Health Services Company (شركة دلّه للخدمات الصحية)

Website

https://dallahhealth.com

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Dallah Healthcare is a publicly listed Saudi integrated healthcare provider operating 13 medical facilities with 2,560+ beds across Saudi Arabia, serving 3.8 million patients annually through hospitals, clinics, home care, pharmaceutical distribution, and facility management services.

Ownership category

akta.pro rank

Product category

Integrated Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)

akta.pro primary industry

International/Medical Tourism Hospital Systems (HLAFAAAN)

akta.pro secondary industry

Provider/Health-System Telehealth + In-House/Owned Pharmacy Integration (HLALAIAB)

Keywords

• Hospital healthcare services
• Outpatient clinic services
• Home healthcare services
• Pharmaceutical distribution
• Healthcare facility management

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Hospital Services Revenue: Revenue from hospital services including inpatient care, outpatient clinics, surgeries, and medical treatments across owned hospitals (Dallah Al Nakheel, Dallah Namar, Dallah Al Khobar, Dallah Al Ahsa, Kingdom Hospital, Makkah Medical Center).
2. Clinic Services Revenue: Revenue from specialized outpatient clinics including Dallah Clinics Al Ared, Qurtabah, Al Yarmouk, Al Salam, and Consulting Clinics.
3. Home Care Services: Physician-supervised home healthcare services including chronic disease management, post-operative rehabilitation, palliative care, teleconsultations, and remote monitoring.
4. Pharmaceutical Distribution: Dallah Pharma manufactures and distributes pharmaceuticals, cosmetics, consumables, medical equipment, and nutritional supplements. Holds exclusive distribution rights for international brands in Saudi Arabia.
5. Facility Management Services: Afyaa Al Nakheel provides facility management services including operation and maintenance of healthcare infrastructure to healthcare institutions.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Dallah Healthcare operates an integrated healthcare delivery platform in Saudi Arabia through owned hospitals, specialized outpatient clinics, physician-supervised home healthcare services, a pharmaceutical manufacturing and distribution arm (Dallah Pharma), and a healthcare facility management subsidiary (Afyaa Al Nakheel). The company serves more than 3.8 million patients annually across 13 medical facilities with over 2,560 beds and 820 outpatient clinics, and also supplies pharmaceutical products and medical devices to retail pharmacies, hospitals, and government entities across Saudi Arabia and the GCC.

Product overview

Dallah Healthcare operates as a diversified healthcare platform offering integrated services through multiple product lines: Dallah Hospitals (acute care hospital network with over 2,560 beds across 6+ hospitals), Dallah Clinics (outpatient specialty clinic network), Dallah Home Care (physician-supervised home healthcare and teleconsultations), Afyaa Al Nakheel (facilities management for healthcare institutions), Dallah Pharma (pharmaceutical distribution and manufacturing), and Dallah Health Investments (strategic investment portfolio). The company also offers telemedicine services and is expanding through digital transformation and new hospital construction.

Differentiator

Problem solved

Functional benefit

Brands

• Dallah Pharma: Pharmaceutical and medical device arm of Dallah Health, manufacturing and distributing pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements
• Afyaa Al Nakheel
• Dallah Home Care
• Dallah Clinics

Products and services

• Dallah Hospitals Integrated acute care, surgical services, and specialized medical treatment across the Dallah hospital network including Dallah Al Nakheel (Riyadh), Dallah Namar (Riyadh), Dallah Al Khobar, Dallah Al Ahsa, and Kingdom Hospital, with over 2,560 beds and 820 outpatient clinics.
• Dallah Clinics Network of specialized outpatient clinics providing primary and specialty care across multiple locations in Saudi Arabia including Al Ared, Qurtabah, Al Yarmouk, Al Salam, and Consulting Clinics.
• Dallah Home Care Physician-supervised medical services delivered in patient homes, including chronic disease management, post-surgical rehabilitation, palliative care, teleconsultations, and remote monitoring.
• Afyaa Al Nakheel Facilities management services for healthcare institutions, including operation and maintenance of healthcare infrastructure, safety compliance frameworks, and occupational health systems.
• Dallah Pharma Pharmaceutical and medical device manufacturing and distribution of pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements, holding exclusive distribution rights for several international brands in Saudi Arabia.

Quantifiable outcome

• 3.8 million+ patient visits annually, up from 2.8 million in 2024 (35.7% increase)
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Tadom Development CompanycoreStrategic or Co-development Partner · 19 November 2025Strategic partner in the Wahat Al-Nakheel Real Estate Fund alongside Dallah Health and Dallah Real Estate. Signed SAR 741 million agreement for mixed-use development project next to Dallah Al-Nakheel Hospital.
• Makkah Medical CentercoreStrategic or Co-development PartnerDallah Health holds 93% ownership in Makkah Medical Center, making it a subsidiary providing healthcare services in Makkah. This is a core investment in the company's portfolio strengthening its presence in the holy city.
• International Medical Center Company (IMC), JeddahminorStrategic or Co-development PartnerDallah Health holds 27.18% stake in International Medical Center Company in Jeddah, an affiliate hospital expanding the company's footprint in the Western region of Saudi Arabia.
• Meras Arabia Medical Holding CompanyminorStrategic or Co-development PartnerDallah Health holds 17% stake in Meras Arabia Medical Holding Company, representing an investment in healthcare sector expansion.
• B-Tab (South Africa)minorChannel Partner/ Reseller/ DistributorExclusive distribution rights for B-Tab pharmaceutical products in Saudi Arabia through Dallah Pharma.
• Ethnofarm (Canada)minorChannel Partner/ Reseller/ DistributorExclusive distribution rights for Ethnofarm pharmaceutical products in Saudi Arabia through Dallah Pharma.
• Herbadal (USA)minorChannel Partner/ Reseller/ DistributorExclusive distribution rights for Herbadal pharmaceutical products in Saudi Arabia through Dallah Pharma.
• Borner (Germany)minorChannel Partner/ Reseller/ DistributorExclusive distribution rights for Borner pharmaceutical products in Saudi Arabia through Dallah Pharma.
• Bourne (France)minorChannel Partner/ Reseller/ DistributorExclusive distribution rights for Bourne pharmaceutical products in Saudi Arabia through Dallah Pharma.
• Biossidas (Argentina)minorChannel Partner/ Reseller/ DistributorExclusive distribution rights for Biossidas pharmaceutical products in Saudi Arabia through Dallah Pharma.

Scale indicators15 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• National Medical Care Company (Care): Saudi-listed (Tadawul) private hospital and healthcare operator. Directly comparable in size, regional footprint, and the mix of hospital and ancillary services targeting the same insured Saudi patient base.
• Dr. Sulaiman Al Habib Medical Group (HMG): Largest private hospital group in Saudi Arabia operating multi-specialty hospitals, clinics, and pharmacies. Direct competitor to Dallah in Riyadh and the Eastern Province with comparable JCI-accredited facilities, similar patient volumes, and a parallel Vision 2030-aligned expansion strategy.
• Fakeeh Care Group (Dr. Soliman Fakeeh Hospital): Saudi private hospital group with flagship Jeddah operations and growing presence in Riyadh. Competes with Dallah in tertiary/specialty care and shares a similar Saudi-focused, multi-segment healthcare delivery model.
• Mouwasat Medical Services Company: Saudi-listed (Tadawul) private hospital operator with a multi-city network in the Eastern Province and beyond. Comparable in scale, business model, and target patient segments, making it the closest publicly traded peer for benchmarking utilization, ARPP, and expansion velocity.
• Saudi German Health (Saudi German Hospitals Group): Major private hospital network with facilities across Saudi Arabia and other MENA markets. Competes directly with Dallah for insured and medical-tourism patients, with a comparable multi-specialty acute-care model.
• Al Hammadi Hospitals: Saudi-listed (Tadawul) private hospital operator concentrated in Riyadh. Competes with Dallah Al Nakheel and Dallah Namar for the same Riyadh insured patient population and offers similar JCI-accredited tertiary services.

Regional players

• Aster DM Healthcare: GCC-headquartered hospital and clinic operator with significant Saudi Arabia presence (Aster Sanad). Operates in adjacent geographies (UAE, India, Oman) and competes for medical-tourism flows, making it comparable as a regional private hospital peer even though it is not Saudi-domestic.

Broad incumbents

• IHH Healthcare Berhad: One of the world's largest hospital operators with footprint across Malaysia, Turkey, Singapore, and India. Comparable as a publicly traded diversified hospital platform with international medical-tourism exposure; relevant for cap-structure and acquisition-rollup benchmarking.
• King Faisal Specialist Hospital & Research Centre (KFSH&RC): Saudi semi-government tertiary/quaternary hospital with national reach. While non-profit and not a direct private-sector competitor, it sets the clinical benchmark Dallah's specialty programs must match and is the dominant referral destination for complex cases.

Others

• Bupa Arabia for Cooperative Insurance: Largest health insurer in Saudi Arabia and a key Dallah payor / commercial-counterparty. Several Dallah executives (CMO, CCO) previously held senior roles at Bupa Arabia. Not a clinical competitor but a critical ecosystem participant — payor relationships and reimbursement terms drive Dallah's realized revenue per case.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/dallahhealth
• LinkedInlinkedin.com/company/dallah-healthcare-holding-co

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dallah Healthcare